Pulmonary cysts of birt-hogg-dubé syndrome: A clinicopathologic and immunohistochemical study of 9 families

American Journal of Surgical Pathology

Volumn 36, Issue 4, 2012, Pages 589-600

  Furuya, Mitsuko ^a   Tanaka, Reiko ^b   Koga, Shunsuke ^c   Yatabe, Yasushi ^d   Gotoda, Hiroko ^f   Takagi, Seiji ^g   Hsu, Yung Hsiang ^l   Fujii, Takeshi ^h   Okada, Akira ⁱ   Kuroda, Naoto ^j   Moritani, Suzuko ^e   Mizuno, Hideki ^e   Nagashima, Yoji ^a   Nagahama, Kiyotaka ^a   Hiroshima, Kenzo ^k   Yoshino, Ichiro ^c   Nomura, Fumio ^c   Aoki, Ichiro ^a   Nakatani, Yukio ^c  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^f Sapporo Kosei General Hospital   (Japan)

^g Department of Urology   (Japan)

^h TORANOMON HOSPITAL   (Japan)

ⁱ NISHI NIIGATA CHUO NATIONAL HOSPITAL   (Japan)

^j KOCHI RED CROSS HOSPITAL   (Japan)

^k Tokyo Women s Medical University   (Japan)

^l BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

more..

Author keywords

Birt Hogg Dub syndrome; folliculin; mTOR; pulmonary cysts; renal tumors

Indexed keywords

FLCN PROTEIN, HUMAN; MTOR PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN S6; TARGET OF RAPAMYCIN KINASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BIRT HOGG DUBE SYNDROME; CYST; FAMILY HEALTH; FEMALE; GENETICS; HAMARTOMA; HUMAN; LUNG; LUNG ALVEOLUS CELL; LUNG DISEASE; MALE; METABOLISM; MIDDLE AGED; MULTIPLE CANCER; MUTATION; PATHOLOGY; PNEUMOTHORAX;

ADULT; AGED; BIRT-HOGG-DUBE SYNDROME; CYSTS; FAMILY HEALTH; FEMALE; HAMARTOMA; HUMANS; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; PNEUMOCYTES; PNEUMOTHORAX; PROTO-ONCOGENE PROTEINS; RIBOSOMAL PROTEIN S6; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84859066969     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182475240     Document Type: Article

References (32)

1. Ayo DS, Aughenbaugh GL, Yi ES, et al. Cystic lung disease in Birt- Hogg-Dube syndrome. Chest. 2007;132:679-684.
2. Baba M, Furihata M, Hong SB, et al. Kidney-targeted Birt-Hogg- Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst. 2008;100:140-154.
3. Baba M, Hong SB, Sharma N, et al. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci USA. 2006;103:15552-15557.
4. Boris RS, Benhammou J, Merino M, et al. The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma. J Urol. 2011;185:2050-2055.
5. Butnor KJ, Guinee DG Jr. Pleuropulmonary pathology of Birt- Hogg-Dube syndrome. Am J Surg Pathol. 2006;30:395-399.
6. Graham RB, Nolasco M, Peterlin B, et al. Nonsense mutations in folliculin presenting as isolated familial spontaneous pneumothorax in adults. Am J Respir Crit Care Med. 2005;172:39-44.
7. Gunji Y, Akiyoshi T, Sato T, et al. Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax. J Med Genet. 2007;44:588-593.
8. Hartman TR, Nicolas E, Klein-Szanto A, et al. The role of the Birt- Hogg-Dube protein in mTOR activation and renal tumorigenesis. Oncogene. 2009;28:1594-1604.
9. Hasumi H, Baba M, Hong SB, et al. Identification and characterization of a novel folliculin-interacting protein FNIP2. Gene. 2008; 415:60-67.
10. Hasumi Y, Baba M, Ajima R, et al. Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci USA. 2009;106:18722-18727.
11. Hudon V, Sabourin S, Dydensborg AB, et al. Renal tumour suppressor function of the Birt-Hogg-Dube syndrome gene product folliculin. J Med Genet. 2010;47:182-189.
12. Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSCmTOR pathway in human disease. Nat Genet. 2005;37:19-24.
13. Inoki K, Li Y, Xu T, et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003; 17:1829-1834.
14. Koga S, FuruyaM, Takahashi Y, et al. Lung cysts in Birt-Hogg-Dube syndrome: histopathological characteristics and aberrant sequence repeats. Pathol Int. 2009;59:720-728.
15. Kunogi M, Kurihara M, Ikegami TS, et al. Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. J Med Genet. 2010;47:281-287.
16. Mahlapuu M, Enerback S, Carlsson P. Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development. 2001;128:2397-2406.
17. Murakami T, Sano F, Huang Y, et al. Identification and characterization of Birt-Hogg-Dube associated renal carcinoma. J Pathol. 2007;211:524-531.
18. Nagy A, Zoubakov D, Stupar Z, et al. Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma. Int J Cancer. 2004;109:472-475.
19. Nickerson ML, Warren MB, Toro JR, et al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome. Cancer Cell. 2002;2:157-164.
20. Pavlovich CP, Walther MM, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol. 2002;26:1542-1552.
21. Petersson F, Gatalica Z, Grossmann P, et al. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch. 2010;456: 355-365.
22. Pittet O, Christodoulou M, Staneczek O, et al. Diagnosis of Birt- Hogg-Dube syndrome in a patient with spontaneous pneumothorax. Ann Thorac Surg. 2006;82:1123-1125.
23. Schmidt LS, Nickerson ML, Warren MB, et al. Germline BHDmutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome. Am J Hum Genet. 2005;76:1023-1033.
24. Takagi Y, Kobayashi T, Shiono M, et al. Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel Fnip1-like (FnipL/ Fnip2) protein. Oncogene. 2008;27:5339-5347.
25. Tobino K, Gunji Y, Kurihara M, et al. Characteristics of pulmonary cysts in Birt-Hogg-Dube syndrome: thin-section CT findings of the chest in 12 patients. Eur J Radiol. 2011;77:403-409.
26. Toro JR, Glenn G, Duray P, et al. Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia. Arch Dermatol. 1999;135: 1195-1202.
27. Toro JR, Pautler SE, Stewart L, et al. Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dube syndrome. Am J Respir Crit Care Med. 2007; 175:1044-1053.
28. Toro JR, Wei MH, Glenn GM, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports. J Med Genet. 2008;45:321-331.
29. Warburton D, Zhao J, Berberich MA, et al. Molecular embryology of the lung: then, now, and in the future. Am J Physiol. 1999; 276:L697-L704.
30. Warren MB, Torres-Cabala CA, Turner ML, et al. Expression of Birt-Hogg-Dube gene mRNA in normal and neoplastic human tissues. Mod Pathol. 2004;17:998-1011.
31. Wei MH, Blake PW, Shevchenko J, et al. The folliculin mutation database: an online database of mutations associated with Birt- Hogg-Dube syndrome. Hum Mutat. 2009;30:E880-E890.
32. Zbar B, Alvord WG, Glenn G, et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg- Dube syndrome. Cancer Epidemiol Biomarkers Prev. 2002;11: 393-400.